Letter from Michael B Rodell, Vice President of Revlon Health Care Group (Armour) to Dr Duncan Thomas, Head of the Division of Blood Products at the National Institute for Biological Standards and Control, re Interim Summary Statement of Hepatitis B Core Antibody Testing Study Group